![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/intron-development-of-phageria-anti-cancer-candidate-with-enhanced-antimicrobial-activity-by-robot-bacteriophage-platform-technology-302062490.html
https://www.prnewswire.com/news-releases/intron-executes-evaluation-license-and-option-agreement-for-sal200-301972235.html
https://www.prnewswire.com/news-releases/intron-signs-bacteriophage-development-project-with-us-army-devcom-301916586.html
https://www.prnewswire.com/news-releases/intron-identifies-prophage-and-jamphage-in-the-pancreatic-cancer-related-microbiome-301836795.html
https://www.prnewswire.com/news-releases/intron-confirms-efficacy-of-cdl200-against-cdi-clinical-isolates-301584277.html
https://www.prnewswire.com/news-releases/intron-completes-glp-tox-studies-of-bal200-301549771.html
https://www.prnewswire.com/news-releases/intron-biotechnology-inc-launches-new-website-301538065.html
http://www.koreabiomed.com/news/articleView.html?idxno=9043
https://endpts.com/roivant-joins-forces-with-koreas-intron-bio-to-fight-superbugs-evotec-inks-deal-to-leverage-ai-to-develop-drugs/